the cliff
Patent cliff
Drugs ranked by the soonest barrier to generic / biosimilar entry. Each row shows the earliest-expiring patent OR FDA exclusivity for that drug — whichever falls first determines when competitive pressure begins.
- Feb 11, 20303.4ypatentCETIRIZINE HYDROCHLORIDECETIRIZINE HYDROCHLORIDEPL Developments Copiague LLC
- Feb 11, 20303.4yNCEGomeklimirdametinibSpringWorks Therapeutics Inc
- Feb 12, 20303.4ypatentALVIMOPANALVIMOPANPar Pharmaceutical Inc
- Feb 14, 20303.4yNCERomvimzavimseltinibOno Pharmaceutical Co Ltd
- Feb 24, 20303.4ypatentTAZAROTENETAZAROTENE$GRIGRI Bio, Inc.
- Mar 11, 20303.5ypatentIDELALISIBIDELALISIB$GILDGILEAD SCIENCES, INC.
- Mar 24, 20303.5ypatentOtovel(ciprofloxacin hydrochloride + fluocinolone acetonide)SALVAT USA Inc
- Mar 28, 20303.5yNCEQfitliafitusiran [INN]Genzyme Corp
- Apr 2, 20303.5ypatentKovanaze(oxymetazoline hydrochloride + tetracaine hydrochloride)St Renatus LLC
- Apr 7, 20303.6ypatentTOLVAPTANTOLVAPTANOtsuka America Pharmaceutical Inc
- Apr 9, 20303.6ypatentBRIVARACETAMBRIVARACETAMUCB SA
- Apr 17, 20303.6ypatentTICAGRELORTICAGRELORHisun Pharmaceutical USA Inc
- Apr 19, 20303.6ypatentCelecoxib GreenstonecelecoxibGreenstone LLC
- Apr 23, 20303.6ypatentLicartdiclofenacIBSA Pharma Inc
- Apr 23, 20303.6ypatentIndomethacinindomethacinACP Nimble Buyer Inc
- May 26, 20303.7ypatentQamzovameloxicamNanjing Delova Biotech Co Ltd
- May 26, 20303.7ypatentVenclextavenetoclax$ABBVAbbVie Inc.
- May 28, 20303.7ypatentSymbicort Aerosphere(budesonide + formoterol fumarate)AstraZeneca Pharmaceuticals LP
- May 28, 20303.7ypatentBevespi Aerosphere(formoterol fumarate + glycopyrrolate)AstraZeneca Pharmaceuticals LP
- May 28, 20303.7yNCETryptyracoltremon$ALCALCON INC
- Jun 2, 20303.7ypatentStivargaregorafenibBayer AG
- Jun 7, 20303.7ypatentParlodelbromocriptine mesylateValidus Pharmaceuticals LLC
- Jun 11, 20303.7yNCEIbtrozitaletrectinib adipate$NUVBNuvation Bio Inc.
- Jun 16, 20303.8ypatentSumatriptansumatriptan [INN]Florida Pharmaceutical Products LLC
- Jun 17, 20303.8ypatentSimbrinza(brimonidine tartrate + brinzolamide)$NVSNOVARTIS AG
- Jun 21, 20303.8ypatentIdhifaenasidenib mesylateBristol-Myers Squibb Co
- Jun 24, 20303.8ypatentAristadaaripiprazole lauroxilAlkermes US Holdings Inc
- Jul 2, 20303.8yNCEZegfrovysunvozertinibDizal Pharmaceutical Co Ltd
- Jul 3, 20303.8yNCEEkterlysebetralstat [INN]$KALVKalVista Pharmaceuticals, Inc.
- Jul 13, 20303.8ypatentSegluromet(ertugliflozin + metformin hydrochloride)$MRKMerck & Co., Inc.
- Jul 13, 20303.8ypatentERTUGLIFLOZINERTUGLIFLOZIN$MRKMerck & Co., Inc.
- Jul 21, 20303.8ypatentAuryxiaferric citrate$AKBAAkebia Therapeutics, Inc.
- Jul 23, 20303.9yNCEAnzupgodelgocitinibLeo Pharma AS
- Jul 28, 20303.9ypatentXospatagilteritinib fumarateAstellas Pharma US Inc
- Jul 28, 20303.9yNCESephiencesepiapterin$PTCPTC INC.
- Jul 29, 20303.9ypatentParsabivetelcalcetide hydrochloride$AMGNAMGEN INC
- Jul 31, 20303.9yNCEVizzaceclidine$LENZLENZ Therapeutics, Inc.
- Aug 2, 20303.9ypatentAllegrafexofenadine hydrochlorideChattem Inc
- Aug 6, 20303.9yNCEModeysodordaviprone hydrochloride$JAZZJazz Pharmaceuticals plc
- Aug 12, 20303.9yNCEBrinsupribrensocatib$INSMINSMED Inc
- Aug 14, 20303.9yODE-438Melblezmelphalan hydrochloride$DCTHDELCATH SYSTEMS, INC.
- Aug 28, 20304.0ypatentBrexafemmeibrexafungerp citrate$GSKGSK plc
- Aug 29, 20304.0yNCEWayrilzrilzabrutinib$SNYSanofi
- Aug 31, 20304.0ypatentBETAMETHASONE DIPROPIONATEBETAMETHASONE DIPROPIONATEPerrigo New York Inc
- Sep 1, 20304.0ypatentLUMISIGHTPEGULICIANINELUMICELL
- Sep 21, 20304.0ypatentCeftaroline Fosamilceftaroline fosamilApotex Corp
- Sep 22, 20304.0ypatentGLYCEROL PHENYLBUTYRATEGLYCEROL PHENYLBUTYRATELupin Ltd
- Sep 25, 20304.0yNCEInluriyoimlunestrant tosylateEli Lilly and Co
- Sep 25, 20304.0yNCEPalsonifypaltusotine hydrochloride$CRNXCrinetics Pharmaceuticals, Inc.
- Sep 30, 20304.0yNCERhapsidoremibrutinib$NVSNOVARTIS AG
sourced from FDA Orange Book · approved drugs only · biologics + biosimilars excluded (those live in the Purple Book — coming soon)